Alan R. Dyer, PhD

Professor and Associate Chair

Dr. Dyer, a biostatistician/epidemiologist, conducts research that focuses on cardiovascular and nutritional epidemiology, particularly the role of nutritional factors in the development of high blood pressure; prevention and control of overweight and obesity, and the implementation and use of statistical methods to correct for "regression dilution bias" when exposures are measured with error.

Research Interests

His research interests include nutritional factors related to blood pressure; corrections for measurement error in regression analyses using assessments of dietary intake; risk factors for cardiovascular diseases in young adult, middle-aged, and older men and women; and relation of overweight and obesity to blood pressure and cardiovascular disease.

He is Principal Investigator of the Data Coordinating Center for the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study and Co-Principal Investigator of the INTERMAP Study.

Recent Publications

1. Dyer AR, Stamler J, Garside DG, Greenland P. Long-term consequences of body mass index for cardiovascular mortality: the Chciago Heart Association Detection Project in Industry Study. Ann Epidemiol 2004;14:101-8.

2. Daviglus ML, Liu K, Yan LL, Pirzada A, Garside DB, Schiffer L, Dyer AR, Greenland P, Stamler J. Body Mass Index in Middle Age and Health-Related Quality of Life in Older Age: The Chicago Heart Association (CHA) Detection Project in Industry Study. Arch Int Med 2003;163:2448-55.

3. Dyer AR, Elliott P, Chan Q, Stamler J, Ueshima H, Zhou BF for the INTERMAP Research Group. Dietary intake in male and female smokers, ex-smokers, and never smokers: The INTERMAP Study. J Human Hypertens 2003;17:641-54.

4. Greenland P, Knoll MD, Stamler J, Neaton J, Dyer AR, Garside DB, Wilson PW. Prevalence of Major risk factors as antecedents of fatal and non-fatal coronary events: data from three U.S. cohorts. JAMA 2003;290:891-7.

5. HAPO Cooperative Study Research Group. The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Intl J Gynaecol Obstet 2002;78:69-77.

6. Fitzgibbon ML, Stolley MR, Dyer AR, Van Horn L, Kaufer-Christoffel K. A community-based obesity prevention program for minority children: rationale and study design for Hip-Hop to Health Jr. Prev Med 2002;34:289-97.

7. Miura K, Dyer AR, Greenland P, Daviglus ML, Hill MA, Liu K, Garside DB, Stamler J. Pulse pressure compared with other blood pressure indixes in the prediction of 25-year cardiovascular and all-cause mortality rates. The Chicago Heart Association Detection Project in Industry. Hypertension 2001;38:232-7.

8. Dyer AR, Stamler J, Greenland P. Associations of weight change and weight variability with cardiovascular and all-cause mortality in the Chicago Western Electric Company Study. Am J Epidemiol 2000;152:324-33.

9. Carnethon MR, Yan L, Greenland P, Garside DB, Dyer AR, Metzger B, Daviglus ML. Resting heart rate in middle age and diabetes development in older age. Diabetes Care. 2007 Oct 24.

10. Berry JD, Dyer A, Carnethon M, Tian L, Greenland P, Lloyd-Jones. Association of traditional risk factors with cardiovascular death across 0 to 10, 10 to 20, and >20 years follow-up in men and women. Am J Cardiol. 2008 Jan 1;101(1):89-94.
11. Rhew EY, Lee C, Eksarko P, Dyer A, Tily H, Spies S, Pope SM, Ramsey-Goldman R. Homocysgeine, bone mineral density, and fracture risk over 2 years of follow up women with and without spestemic lupus erythematousus. J Rheumatol. 2008 Jan 15.
12. Desrivieres S, Krause K, Dyer A, Frank J, Blomeyer D, Lathrop M, Mann K, Banaschewski T, Laucht M, Schumann G. Nucleotide sequence variation within the PI3K p85 alpha gene associates with alcohol risk drinking behavior in adolescents. PloS One. 2008 Mar 12;3(3):e1769.
13. Dyer AR, Burdock GA, Carabin IG, Haas MC, Boyce J, Alsaker R, Read LC. In vitro and in vivo safety studies of a proprietary when extract. Food Chem Toxicol. 2008 May;46(5):1659-65. Epub 2008 Jan 17.
14. Goldberger JJ, Bonow RO, Cuffe M, Dyer A, Greenland P, Rosenberg Y, O'Rourke R, Shah PK, Smith S. Post-myocardial infarction beta-blocker therapy: The bradycardia conundrum. Rational and design for the pacemaker & betablocker therapy post-MI(PACE-MI) trial. Am Heart J. 2008 Mar;155(3):455-64. Epub 2008 Jan 31. Review.
15. HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarinr U, Coustan DR, Hadden DR, McCance DR, Hod M, McIntyre HD, Oats JJ, Persson B, Rogers MS, Sacks DA. Hyperglycermia and adverse pregnancy outcomes. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008 May 8;358(19):1991-2002.

PHONE: 312-908-7914
E-MAIL: